IL1B and tuberculosis: The emergence of the complement-associated inflammasome signaling pathway after ART initiation may contribute to TB-IRIS immunopathology, since it correlates with IL-1β and IL-18 plasma levels and its decay is associated with dampening in IRIS-related symptoms promoted by anti-inflammatory therapy.